Heterocyclic Anticancer Agents

Bimal Krishna Banik, Bubun Banerjee

Research output: Book/ReportBookpeer-review

6 Scopus citations

Abstract

Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles. Explores heterocycles and their use as anticancer therapies. Contains chapters on various heterocyclic derrivatives, the impact of heterocycles on anticancer agent development, and naturally occuring heterocycles.

Original languageEnglish
Publisherde Gruyter
Number of pages512
ISBN (Electronic)9783110735772
ISBN (Print)9783110739268
DOIs
StatePublished - 21 Jun 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Heterocyclic Anticancer Agents'. Together they form a unique fingerprint.

Cite this